Viewing Study NCT01706120


Ignite Creation Date: 2025-12-25 @ 4:26 AM
Ignite Modification Date: 2026-03-10 @ 11:51 PM
Study NCT ID: NCT01706120
Status: UNKNOWN
Last Update Posted: 2023-03-24
First Post: 2012-10-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab
Sponsor: National Cancer Institute, Naples
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module